Jacob K.R. Jamison

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Gulam Abbas Manji · 5 shared papers, 2023–2026 · strength 1.10
   • Paper Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastati… DOI 10.1093/oncolo/oyag091↗
   • Paper A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX. DOI 10.1093/oncolo/oyad315↗
   • Paper Low Bacterial Biomass in Human Pancreatic Cancer and Adjacent Normal Tissue. DOI 10.3390/ijms26010140↗
2. Michael S. May · 4 shared papers, 2023–2025 · strength 0.84
   • Paper A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX. DOI 10.1093/oncolo/oyad315↗
   • Paper Low Bacterial Biomass in Human Pancreatic Cancer and Adjacent Normal Tissue. DOI 10.3390/ijms26010140↗
   • Paper Smoking is Not Associated with Lung Metastasis in Pancreatic Cancer. DOI 10.1080/07357907.2023.2203747↗
3. Alexander Grenander Raufi · 3 shared papers, 2023–2025 · strength 0.62
   • Paper A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX. DOI 10.1093/oncolo/oyad315↗
   • Paper Smoking is Not Associated with Lung Metastasis in Pancreatic Cancer. DOI 10.1080/07357907.2023.2203747↗
   • Paper Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma. DOI 10.1038/s41588-025-02345-5↗
4. Susan Elaine Bates · 1 shared paper, 2026 · strength 0.26
   • Paper Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastati… DOI 10.1093/oncolo/oyag091↗
5. Naomi Yamamoto · 1 shared paper, 2026 · strength 0.26
   • Paper Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastati… DOI 10.1093/oncolo/oyag091↗
6. Ruth Aroon White · 1 shared paper, 2026 · strength 0.26
   • Paper Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastati… DOI 10.1093/oncolo/oyag091↗
7. Sita Kugel · 1 shared paper, 2026 · strength 0.26
   • Paper Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastati… DOI 10.1093/oncolo/oyag091↗
8. Tamas A. Gonda · 1 shared paper, 2026 · strength 0.26
   • Paper Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastati… DOI 10.1093/oncolo/oyag091↗
9. Rachael Ann Safyan · 1 shared paper, 2026 · strength 0.26
   • Paper Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastati… DOI 10.1093/oncolo/oyag091↗
10. Paul E. Oberstein · 1 shared paper, 2026 · strength 0.26
    • Paper Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastati… DOI 10.1093/oncolo/oyag091↗
11. Lyndon Luk · 1 shared paper, 2024 · strength 0.24
    • Paper A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX. DOI 10.1093/oncolo/oyad315↗
12. Alfred I. Neugut · 1 shared paper, 2023 · strength 0.20
    • Paper Smoking is Not Associated with Lung Metastasis in Pancreatic Cancer. DOI 10.1080/07357907.2023.2203747↗
13. Morteza Chalabi Hajkarim · 1 shared paper, 2025 · strength 0.18
    • Paper Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma. DOI 10.1038/s41588-025-02345-5↗
14. Benjamin Izar · 1 shared paper, 2025 · strength 0.18
    • Paper Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma. DOI 10.1038/s41588-025-02345-5↗
15. Michael D. Kluger · 1 shared paper, 2025 · strength 0.18
    • Paper Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma. DOI 10.1038/s41588-025-02345-5↗
16. Basil S. Bakir · 1 shared paper, 2025 · strength 0.18
    • Paper Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma. DOI 10.1038/s41588-025-02345-5↗
17. John A. Chabot · 1 shared paper, 2025 · strength 0.18
    • Paper Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma. DOI 10.1038/s41588-025-02345-5↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.